Key result
PIP2 potently inhibits the proton-activated chloride (PAC) channel with an IC50 of 4.9 µM by binding to an extracellular site and stabilizing a desensitized-like conformation.
Why the study?
The proton-activated chloride channel contributes to acid-induced cell death, but its pharmacology is poorly understood.
PIP2 potently inhibits the proton-activated chloride (PAC) channel by binding to an extracellular site and stabilizing a desensitized-like conformation, providing a novel pharmacological tool.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for PAC channel modulation; leaves open any clinical translation pending human validation.
Proton-activated chloride (PAC) channel is a ubiquitously expressed pH-sensing ion channel, encoded by PACC1 ( TMEM206 ). PAC regulates endosomal acidification and macropinosome shrinkage by releasing chloride from the organelle lumens. It is also found at the cell surface, where it is activated under pathological conditions related to acidosis and contributes to acid-induced cell death. However, the pharmacology of the PAC channel is poorly understood. Here, we report that phosphatidylinositol (4,5)-bisphosphate (PIP 2 ) potently inhibits PAC channel activity. We solved the cryo-electron microscopy structure of PAC with PIP 2 at pH 4.0 and identified its putative binding site, which, surprisingly, locates on the extracellular side of the transmembrane domain (TMD). While the overall conformation resembles the previously resolved PAC structure in the desensitized state, the TMD undergoes remodeling upon PIP 2 -binding. Structural and electrophysiological analyses suggest that PIP 2 inhibits the PAC channel by stabilizing the channel in a desensitized-like conformation. Our findings identify PIP 2 as a new pharmacological tool for the PAC channel and lay the foundation for future drug discovery targeting this channel.
No takes yet. Share an insight, caveat, or question.
Mihaljević et al. (2023) studied this question. PIP2 (phosphatidylinositol (4,5)-bisphosphate) vs. Baseline/vehicle was evaluated on Inhibition of acid-induced chloride currents (ICl,H) mediated by PAC (IC50 4.9 µM). PIP2 potently inhibits the proton-activated chloride (PAC) channel with an IC50 of 4.9 µM by binding to an extracellular site and stabilizing a desensitized-like conformation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: